These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 36944859)

  • 21. CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica.
    Misa J; Schwartz C
    Methods Mol Biol; 2021; 2307():95-109. PubMed ID: 33847984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Production of carboxylic acids by metabolically engineered
    Rong L; Liu S; Zhu K; Kong J; Miao L; Wang S; Xiao D; Yu A
    Sheng Wu Gong Cheng Xue Bao; 2022 Apr; 38(4):1360-1372. PubMed ID: 35470612
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in biotechnological production of polyunsaturated fatty acids by
    Jia YL; Wang LR; Zhang ZX; Gu Y; Sun XM
    Crit Rev Food Sci Nutr; 2022; 62(32):8920-8934. PubMed ID: 34120537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering of
    Zhang G; Wang H; Zhang Z; Verstrepen KJ; Wang Q; Dai Z
    Crit Rev Biotechnol; 2022 Jun; 42(4):618-633. PubMed ID: 34325575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in synthetic biology tools paving the way for the biomanufacturing of unusual fatty acids using the Yarrowia lipolytica chassis.
    Wang K; Shi TQ; Lin L; Wei P; Ledesma-Amaro R; Ji XJ; Huang H
    Biotechnol Adv; 2022 Oct; 59():107984. PubMed ID: 35609800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplexed CRISPR Activation of Cryptic Sugar Metabolism Enables Yarrowia Lipolytica Growth on Cellobiose.
    Schwartz C; Curtis N; Löbs AK; Wheeldon I
    Biotechnol J; 2018 Sep; 13(9):e1700584. PubMed ID: 29729131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving CRISPR/Cas9-mediated genome editing efficiency in Yarrowia lipolytica using direct tRNA-sgRNA fusions.
    Abdel-Mawgoud AM; Stephanopoulos G
    Metab Eng; 2020 Nov; 62():106-115. PubMed ID: 32758536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New roles for Yarrowia lipolytica in molecules synthesis and biocontrol.
    Sanya DRA; Onésime D
    Appl Microbiol Biotechnol; 2022 Nov; 106(22):7397-7416. PubMed ID: 36241927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What makes Yarrowia lipolytica well suited for industry?
    Park YK; Ledesma-Amaro R
    Trends Biotechnol; 2023 Feb; 41(2):242-254. PubMed ID: 35940976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding Functional Roles of Native Pentose-Specific Transporters for Activating Dormant Pentose Metabolism in Yarrowia lipolytica.
    Ryu S; Trinh CT
    Appl Environ Microbiol; 2018 Feb; 84(3):. PubMed ID: 29150499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic biology and molecular genetics in non-conventional yeasts: Current tools and future advances.
    Wagner JM; Alper HS
    Fungal Genet Biol; 2016 Apr; 89():126-136. PubMed ID: 26701310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous Improvement of Limonene Production and Tolerance in
    Li J; Zhu K; Miao L; Rong L; Zhao Y; Li S; Ma L; Li J; Zhang C; Xiao D; Foo JL; Yu A
    ACS Synth Biol; 2021 Apr; 10(4):884-896. PubMed ID: 33715363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic engineering of Yarrowia lipolytica for the production of isoprene.
    Shaikh KM; Odaneth AA
    Biotechnol Prog; 2021 Nov; 37(6):e3201. PubMed ID: 34369095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A synthetic biology approach to transform Yarrowia lipolytica into a competitive biotechnological producer of β-carotene.
    Larroude M; Celinska E; Back A; Thomas S; Nicaud JM; Ledesma-Amaro R
    Biotechnol Bioeng; 2018 Feb; 115(2):464-472. PubMed ID: 28986998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic engineering of Yarrowia lipolytica for industrial applications.
    Zhu Q; Jackson EN
    Curr Opin Biotechnol; 2015 Dec; 36():65-72. PubMed ID: 26319895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genome integration sites for developing a CRISPR-based gene expression toolkit in Yarrowia lipolytica.
    Liu X; Cui Z; Su T; Lu X; Hou J; Qi Q
    Microb Biotechnol; 2022 Aug; 15(8):2223-2234. PubMed ID: 35436041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene repression via multiplex gRNA strategy in Y. lipolytica.
    Zhang JL; Peng YZ; Liu D; Liu H; Cao YX; Li BZ; Li C; Yuan YJ
    Microb Cell Fact; 2018 Apr; 17(1):62. PubMed ID: 29678175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A teaching protocol demonstrating the use of EasyClone and CRISPR/Cas9 for metabolic engineering of Saccharomyces cerevisiae and Yarrowia lipolytica.
    Milne N; Tramontin LRR; Borodina I
    FEMS Yeast Res; 2020 Mar; 20(2):. PubMed ID: 31556952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A CRISPR/Cas9-Mediated, Homology-Independent Tool Developed for Targeted Genome Integration in Yarrowia lipolytica.
    Cui Z; Zheng H; Zhang J; Jiang Z; Zhu Z; Liu X; Qi Q; Hou J
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33452022
    [No Abstract]   [Full Text] [Related]  

  • 40. Genome Editing, Transcriptional Regulation, and Forward Genetic Screening Using CRISPR-Cas12a Systems in Yarrowia lipolytica.
    Ramesh A; Lee S; Wheeldon I
    Methods Mol Biol; 2024; 2760():169-198. PubMed ID: 38468089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.